Trial
NCT03666728
A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Lung Neoplasms
Intervention
SHR-1210
Why stopped
changes in the R\&D strategy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-17